ANCO - May 2024

Log in

May 2024

05/01/2024 3:02 PM | TheARRC (Administrator)

FDA Approvals

On May 5, 2024, (FDA) Oncology Center of Excellence (OCE) launched the Project 5 in 5 crowdsourcing initiative.

On May 16, 2024, the FDA granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen, Inc.) for extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

Learn More

On May 29, 2024, the FDA granted accelerated approval to selpercatinib (Retevmo, Eli Lilly and Company) for pediatric patients two years of age and older.

Learn More

National Guideline Updates

View the NCCN eBulletin Here

Learn More

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Acute Myeloid Leukemia. These NCCN Guidelines® are currently available as Version 3.2024.

Learn More

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Cervical Cancer. These NCCN Guidelines® are currently available as Version 3.2024.

Learn More

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) for Gastric Cancer. These NCCN Guidelines®are currently available as Version 2.2024.

Learn More

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the NCCN Drugs & Biologics Compendium (NCCN Compendium®), the NCCN Radiation Therapy Compendium™, and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) for Pediatric Hodgkin Lymphoma. These NCCN Guidelines® are currently available as Version 1.2024.

Learn More

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer. These NCCN Guidelines® are currently available as Version 4.2024.

Learn More

NCCN has published updates to the NCCN Chemotherapy Order Templates (NCCN Templates®) for Appendiceal Adenocarcinoma to reflect the currently published NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon Cancer v2.2024.

Learn More

NCCN has published updates to the NCCN Chemotherapy Order Templates (NCCN Templates®) for Head and Neck Cancers to reflect the currently published NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Head and Neck Cancers v4.2024.

Learn More

NCCN has published updates to the NCCN Chemotherapy Order Templates (NCCN Templates®) for Melanoma: Cutaneous to reflect the currently published NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Melanoma: Cutaneous v2.2024.

Learn More

NCCN has published updates to the NCCN Chemotherapy Order Templates (NCCN Templates®) for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer to reflect the currently published NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer v2.2024.

Learn More